ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 102 filers reported holding ENDOCYTE INC in Q2 2014. The put-call ratio across all filers is 4.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $75,000 | +27.1% | 17,428 | -58.4% | 0.00% | – |
Q3 2017 | $59,000 | -49.6% | 41,928 | -45.9% | 0.00% | – |
Q2 2017 | $117,000 | -65.9% | 77,456 | -41.9% | 0.00% | – |
Q1 2017 | $343,000 | +28.0% | 133,270 | +26.7% | 0.00% | – |
Q4 2016 | $268,000 | +9.4% | 105,160 | +32.4% | 0.00% | – |
Q3 2016 | $245,000 | -2.8% | 79,410 | +1.0% | 0.00% | – |
Q2 2016 | $252,000 | +24.8% | 78,635 | +20.3% | 0.00% | – |
Q1 2016 | $202,000 | -18.9% | 65,390 | +5.4% | 0.00% | – |
Q4 2015 | $249,000 | -12.9% | 62,020 | -0.7% | 0.00% | – |
Q3 2015 | $286,000 | +11.7% | 62,460 | +26.4% | 0.00% | – |
Q2 2015 | $256,000 | +13.8% | 49,420 | +37.5% | 0.00% | – |
Q1 2015 | $225,000 | +22400.0% | 35,930 | +26514.8% | 0.00% | – |
Q3 2014 | $1,000 | -96.7% | 135 | -97.1% | 0.00% | – |
Q2 2014 | $30,000 | -90.3% | 4,620 | -64.5% | 0.00% | – |
Q1 2014 | $310,000 | +123.0% | 13,020 | +0.1% | 0.00% | – |
Q4 2013 | $139,000 | -29.8% | 13,010 | -12.7% | 0.00% | – |
Q3 2013 | $198,000 | +1.0% | 14,909 | 0.0% | 0.00% | – |
Q2 2013 | $196,000 | – | 14,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corbenic Partners LLC | 32,639 | $83,000 | 0.09% |
Anson Funds Management LP | 108,426 | $276,000 | 0.09% |
Leisure Capital Management | 30,038 | $77,000 | 0.07% |
HIGHLAND CAPITAL MANAGEMENT LP | 461,561 | $1,177,000 | 0.06% |
Teza Capital Management LLC | 14,542 | $37,000 | 0.05% |
PINNACLE ASSOCIATES LTD | 821,543 | $2,095,000 | 0.04% |
Cribstone Capital Management, LLC | 28,141 | $63,000 | 0.04% |
RMB Capital Management, LLC | 243,385 | $621,000 | 0.03% |
Acrospire Investment Management LLC | 26,061 | $66,000 | 0.03% |
TWO SIGMA SECURITIES, LLC | 26,758 | $68,000 | 0.02% |